A single-facility prospective study for the effectiveness of endoscopic pancreatic duct stenting for gallstones pancreatitis and post-ERCP pancreatitis

A single-facility prospective study for the effectiveness of endoscopic pancreatic duct stenting for gallstones pancreatitis and post-ERCP pancreatitis - PEP-EPS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034578

Enrollment

Registered

2018-10-20

Start date

2018-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallstones pancreatitis, Post-ERCP pancreatitis

Interventions

Total 30 number of post-ERCP pancreatitis and gallstones pancreatitis patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gallstones pancreatitis patients and post-ERCP pancreatitis patients

Exclusion criteria

Exclusion criteria: 1. More than 48 hours from the onset of pancreatitis 2. Intraductal papillary mucinous neoplasm (IPMN) patients 3. Patients who did not receive concent

Design outcomes

Primary

Measure	Time frame
Measurement of golden time of endoscopic intervention for acute obstructive pancreatitis	—

Secondary

Measure	Time frame
Measurement of the ratio of stent obstruction when EPS were performed to acute obstructive pancreatitis	—

Countries

Japan

Contacts

Public ContactHayasaka Kenji

New Tokyo Hospital Department of gastroenterology

dr25027@gk2.so-net.ne.jp81-47-711-8700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026